CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

MannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway

Phase 1positivePositive
AI Analysis

Summary

MannKind's inhaled IPF drug successfully completed Phase 1b safety evaluation with Phase 2 study now underway.

Clinical Trial Data

Phase

1b

Primary Endpoint

Met

Outcome Details

Cleared Phase 1b safety hurdle

Importance:5/10
Sentiment:
0.70
inhaled drugIPFPhase 1bPhase 2safety
Related Companies

Read the original article

Published by yahoo_finance on July 29, 2026 11:04 PM

Read Original